Navidea Biopharmaceuticals, Inc. STTR Phase I Award, September 2019
A STTR Phase I contract was awarded to Navidea Biopharmaceuticals, Inc. in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.